Copyright
©The Author(s) 2021.
World J Clin Cases. May 6, 2021; 9(13): 3163-3169
Published online May 6, 2021. doi: 10.12998/wjcc.v9.i13.3163
Published online May 6, 2021. doi: 10.12998/wjcc.v9.i13.3163
Table 1 Laboratory data
Blood cell count | Normal range | Units | Biochemical examination | Normal range | Units | Arterial blood gas analysis (room air) | Normal range | Units | |||
White blood cell | 11440 | 3300-8600 | /μL | Total protein | 8.2 | 6.6-8.1 | g/dL | pH | 7.182 | 7.350-7.450 | mmHg |
Red blood cell | 489 | 386-492 | × 104/μL | Albumin | 4.5 | 4.1-5.1 | g/dL | paCO2 | 18 | 35.0-45.0 | mmHg |
Hemoglobin | 14.7 | 11.6-14.8 | g/dL | BUN | 9.1 | 8.0-20.0 | mg/dL | paO2 | 115.2 | > 80 | mmol/L |
Hematocrit | 43.6 | 35.1-44.1 | % | Creatinine | 0.4 | 0.46-0.79 | mg/dL | HCO3- | 6.6 | 22.0-26.0 | mmol/L |
Platelet | 28.3 | 15.8-34.8 | × 104/μL | Uric acid | 5.3 | 2.6-5.5 | mg/dL | Base excess | -19.3 | -2.0-+2.0 | mmol/L |
Na | 131 | 138-145 | mEq/L | Anion gap | 27.6 | 10.0-18.0 | mmol/L | ||||
Urinalysis | K | 4.5 | 3.6-4.8 | mEq/L | Lactic acid | 1.0 | 0.9-1.7 | mmHg | |||
Specific gravity | 1.015 | 1.005-1.030 | Cl | 102 | 101-108 | mEq/L | |||||
pH | 5.5 | 4.5-7.5 | Ca | 8.7 | 8.8-10.1 | mg/dL | Blood ketone bodies | ||||
Glucose | 2000 | < 50 | mg/dL | P | 2.6 | 2.7-4.6 | mg/dL | Acetoacetate | 1784 | < 55 | μmol/L |
Protein | 100 | < 30 | mg/dL | AST | 20 | 13-30 | U/L | 3-Hydroxybutyrate | 6585 | < 85 | μmol/L |
Ketone body | (3+) | (-) | ALT | 6 | 7-23 | U/L | |||||
Blood | (±) | (-) | LDH | 251 | 124-222 | U/L | Autoantibodies | ||||
γ-GTP | 43 | 9-32 | U/L | GAD autoantibody | < 5.0 | < 5.0 | U/mL | ||||
Diabetic parameters | ALP | 178 | 106-322 | U/L | IA-2 autoantibody | < 0.6 | < 0.6 | U/mL | |||
HbA1c | 7.3 | 4.9-6.0 | % | T-Bil | 0.5 | 0.4-1.5 | mg/dL | Insulin autoantibody | < 0.4 | < 0.4 | U/mL |
Glycoalbumin | 23.2 | 11.0-16.0 | % | CRP | 0.12 | < 0.14 | mg/dL | Islet cell antibody | (-) | (-) | |
Blood glucose | 184 | 73-109 | mg/dL | Total-cholesterol | 242 | 142-248 | mg/dL | ZnT8 autoantibody | < 10.0 | < 15.0 | U/mL |
Serum C-peptide | 0.3 | 0.6-2.1 | ng/mL | Triglyceride | 230 | 30-117 | mg/dL | ||||
Urine C-peptide | 8.6 | 22.8-155.2 | μg/d | Amylase | 35 | 44-132 | U/L | ||||
Lipase | 23 | 12-51 | U/L |
- Citation: Yasuma T, Okano Y, Tanaka S, Nishihama K, Eguchi K, Inoue C, Maki K, Uchida A, Uemura M, Suzuki T, D'Alessandro-Gabazza CN, Gabazza EC, Yano Y. Sodium-glucose co-transporter-2 inhibitor-associated euglycemic diabetic ketoacidosis that prompted the diagnosis of fulminant type-1 diabetes: A case report . World J Clin Cases 2021; 9(13): 3163-3169
- URL: https://www.wjgnet.com/2307-8960/full/v9/i13/3163.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i13.3163